Medication info
Glimepiride Tablet (Glymepiride)

Glimepiride Tablet (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Sama Pharmaceutical Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets, 100 tablets (bottle)
Approval status
Active

MFDS item code 200400777 · Approved 2004.02.06 · Insurance code 645700010

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using this medicine in combination with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, a dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Sama Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used as an adjunct when diet and exercise are not sufficient for blood sugar control in patients with type 2 diabetes. It can also be used alone, and when blood sugar control is inadequate, it can be used in combination with other oral hypoglycemic agents or insulin. For example, when blood sugar control is difficult with sulfonylureas or metformin monotherapy, this medication can be administered together with metformin to effectively improve blood sugar levels. This allows for smoother blood sugar control and aids in diabetes management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using this medicine in combination with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, a dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. Additionally, individuals allergic to this medication or its components, or with severe liver or kidney dysfunction, should not take it. It is also not safe for pregnant or breastfeeding women to use this medication. Patients with severe infections, pre- and post-surgical conditions, or serious injuries are advised to transition to insulin therapy. Gastrointestinal disturbances such as diarrhea or vomiting can lead to inadequate absorption of the medication, increasing the risk of hypoglycemia. Since this medication contains lactose, it should not be given to patients with specific genetic lactose intolerance. When starting the medication for the first time, there is an increased risk of hypoglycemia, so careful monitoring of blood sugar levels is essential. Elderly patients, those with poor nutritional status or irregular eating patterns, frequent alcohol consumption, and individuals with weakened kidney or liver function should also exercise caution. Furthermore, when taken in conjunction with other medications, it may interact and affect blood sugar control, so consulting with a physician is necessary. This medication lowers blood sugar levels which may cause symptoms of hypoglycemia. Symptoms of hypoglycemia can include headaches, severe hunger, dizziness, fatigue, confusion, drowsiness, and in severe cases, loss of consciousness. Rarely, there may be occurrences of visual disturbances, gastrointestinal symptoms, impaired liver function, blood abnormalities, and allergic reactions. If symptoms such as hives or difficulty breathing occur, contact a physician immediately. When taking this medication, it is crucial to maintain regular meals and exercise, and to regularly check blood sugar levels. If hypoglycemia occurs, sugar or sweetened drinks should be consumed immediately to manage the condition, and having a source of sugar on hand is advisable. In cases of pregnancy or breastfeeding, it is recommended to switch to insulin therapy instead of using this medication. In case of overdose, severe hypoglycemia may occur, so it is important to visit a hospital immediately for appropriate treatment. This medication should be kept out of the reach of children and stored in its original container to maintain its quality.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, dizziness, arthralgia, dyspepsia, facial swelling, erectile dysfunction, hair loss, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The recommended storage temperature is room temperature, between 1°C to 30°C. This helps to maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets, 100 tablets (bottle)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.